Kyowa Kirin Co Ltd - Company Profile
Powered by 
All the data and insights you need on Kyowa Kirin Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Kyowa Kirin Co Ltd Strategy Report
- Understand Kyowa Kirin Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Kyowa Kirin Catalyst Calendar
Proactively evaluate Kyowa Kirin Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Kyowa Kirin Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Oct 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Oct 2019 | Phase II/III Trial Initiation | Kyowa Kirin Co Ltd | 4151 | romiplostim | Hematological Disorders | Aplastic Anemia | Clinical Trial Registry |
| 01 Oct 2019 | Phase II Trial Initiation | ADIR, a Servier Group Co; IQVIA Holdings Inc; Kyowa Kirin Co Ltd; Les Laboratoires Servier SAS; Servier Institute of International Research | 4151; IQV | pegaspargase | Oncology | Acute Lymphoblastic Lymphoma; Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia); Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Clinical Trial Registry |
| 01 Sep 2019 | Phase II Trial Completion | Kyowa Kirin Co Ltd; Oregon Health & Science University | 4151 | citicoline | Undisclosed | Unspecified | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer